Related Experiment Video
Updated: Feb 4, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
[Management of arterial hypertension : ESC/ESH guidelines 2018]
H Schunkert1,2
1Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstr. 36, 80636, München, Deutschland. schunkert@dhm.mhn.de.
The 2018 ESC/ESH guidelines offer updated strategies for managing arterial hypertension in adults. They focus on improving blood pressure control through simple, effective treatments and highlight changes from the 2013 guidelines.
Area of Science:
- Cardiology
- Clinical Practice Guidelines
Background:
- Arterial hypertension remains a significant global health concern.
- Suboptimal blood pressure control rates necessitate updated management strategies.
Purpose of the Study:
- To provide updated, pragmatic guidance for the detection and treatment of arterial hypertension in adults (≥18 years).
- To enhance blood pressure control rates by promoting effective and simple treatment strategies.
- To outline key differences between the 2018 and 2013 hypertension guidelines.
Main Methods:
- Review and synthesis of new scientific findings relevant to hypertension management.
- Development of evidence-based recommendations for clinical practice.
- Comparative analysis with previous guideline iterations (2013).
Main Results:
- The guidelines incorporate recent evidence to refine hypertension treatment protocols.
- Emphasis is placed on practical approaches to improve patient outcomes.
- Key modifications from the 2013 guidelines are detailed.
Conclusions:
- The 2018 ESC/ESH guidelines provide a comprehensive framework for managing adult hypertension.
- Implementation of these guidelines aims to improve hypertension detection and treatment efficacy.
- These updated recommendations support better blood pressure control and patient health.
Related Concept Videos
Hypertension V: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease V: Postoperative Nursing Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

